Valverde, Italy

Antonino Asero

This inventor holds 1 USPTO granted patent. Top assignee: S.i.f.i. Societa Industria Farmaceutica Italiana S.p.a.. Active years: 2001.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Antonino Asero: Innovator in Ophthalmic Formulations

Introduction

Antonino Asero is a notable inventor based in Valverde, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of ophthalmic formulations. His work focuses on improving treatments for ocular bacterial infections.

Latest Patents

Antonino Asero holds a patent for a process for preparing aqueous formulations for ophthalmic use. This invention describes a method for creating aqueous formulations containing azithromycin, which are intended for treating conditions such as conjunctivitis, keratitis, and blepharitis. The patent highlights the importance of effective topical treatments in managing ocular infections.

Career Highlights

Asero is associated with S.I.F.I. Società Industria Farmaceutica Italiana S.p.A., a company dedicated to pharmaceutical innovation. His role in the company has allowed him to contribute to advancements in eye care and treatment options for patients suffering from various eye conditions.

Collaborations

Throughout his career, Antonino Asero has collaborated with esteemed colleagues, including Maria Grazia Mazzone and Anna Rita Blanco. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the pharmaceutical field.

Conclusion

Antonino Asero's work in developing ophthalmic formulations demonstrates his commitment to improving healthcare solutions. His patent for an aqueous formulation containing azithromycin is a testament to his innovative spirit and dedication to addressing ocular bacterial infections.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…